Left Menu
Development News Edition

Eli Lilly in deal to supply COVID-19 drugs to low-income countries

The drugmaker in September partnered with Amgen Inc to increase supply of its antibody therapies, a day after data showed that Lilly's single antibody therapy, LY-CoV555, helped cut hospitalization and emergency room visits for COVID-19 patients. Fujifilm said in a statement it expects to begin manufacturing of Lilly's antibody therapy in April 2021.

Reuters | Updated: 09-10-2020 07:08 IST | Created: 09-10-2020 07:08 IST
Eli Lilly in deal to supply COVID-19 drugs to low-income countries

Eli Lilly and Co said on Thursday it had entered into an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for COVID-19 to low and middle-income countries.

As part of the deal, Lilly said it will make antibody therapies available to lower-income countries prior to April 2021, but did not elaborate on the number of doses. Separately, Fujifilm Holdings Corp said its facility in Denmark would manufacture treatments next year. Lilly had previously said it would make one million doses of its single antibody treatment available by the end of the year, and another 50,000 doses of its dual-antibody therapy by the fourth quarter this year.

Lilly said its partners with which it is developing antibody therapies, including Canadian biotech company AbCellera Biologics Inc, had agreed to waive their royalties on the therapies distributed in low- and middle-income countries. The drugmaker in September partnered with Amgen Inc to increase supply of its antibody therapies, a day after data showed that Lilly's single antibody therapy, LY-CoV555, helped cut hospitalization and emergency room visits for COVID-19 patients.

Fujifilm said in a statement it expects to begin manufacturing of Lilly's antibody therapy in April 2021. In June, the company said its subsidiary Fujifilm Diosynth Biotechnologies would double capacity at its Danish facility, which it has pledged to use in making COVID-19 treatments. A dual-antibody combination also showed similar results on Wednesday. Lilly plans to seek U.S. emergency use authorization for that combination next month.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Videos

Latest News

Mexico registers 11,625 new coronavirus cases, 593 more deaths

Mexicos Health Ministry on Saturday reported 11,625 new confirmed cases of coronavirus infection and an additional 593 fatalities, bringing the total in the country to 1,168,395 cases and 109,456 deaths.The government says the real number o...

Trump stumps in Georgia for two Republican candidates while pressing vote fraud claims

U.S. President Donald Trump campaigned in Georgia on Saturday for two Republican senators at a rally that some in his party fear could end up hurting, not helping, their chances if he focuses on efforts to reverse his own election defeat. I...

S.Korea to consider new curbs as coronavirus cases hit 9-month high

South Korea on Sunday reported 631 new coronavirus cases, the highest in nine months, ahead of an expected government decision on whether to further tighten social distancing curbs as health authorities struggle to contain a third wave of o...

UK cabinet to back Johnson over no-deal Brexit -The Times

UK cabinet ministers said they will back Prime Minister Boris Johnson over a no-deal Brexit, The Times reported httpswww.thetimes.co.ukeditionnewscabinet-backs-boris-johnson-over-no-deal-brexit-fccwzj6mt on Sunday.A total of thirteen cabine...

Give Feedback